ATE88188T1 - Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. - Google Patents

Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.

Info

Publication number
ATE88188T1
ATE88188T1 AT90400203T AT90400203T ATE88188T1 AT E88188 T1 ATE88188 T1 AT E88188T1 AT 90400203 T AT90400203 T AT 90400203T AT 90400203 T AT90400203 T AT 90400203T AT E88188 T1 ATE88188 T1 AT E88188T1
Authority
AT
Austria
Prior art keywords
factor
preparation
high purity
antihaemophilic
exhibiting high
Prior art date
Application number
AT90400203T
Other languages
English (en)
Inventor
Bernard Jules Dazey
Mohamed Hamsany
Gerard Paul Vezon
Original Assignee
Aquitaine Dev Transf Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE88188(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquitaine Dev Transf Sanguine filed Critical Aquitaine Dev Transf Sanguine
Application granted granted Critical
Publication of ATE88188T1 publication Critical patent/ATE88188T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT90400203T 1989-02-17 1990-01-24 Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. ATE88188T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8902136A FR2644064B1 (fr) 1989-02-17 1989-02-17 Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant

Publications (1)

Publication Number Publication Date
ATE88188T1 true ATE88188T1 (de) 1993-04-15

Family

ID=9378912

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400203T ATE88188T1 (de) 1989-02-17 1990-01-24 Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.

Country Status (7)

Country Link
EP (1) EP0383645B1 (de)
JP (1) JP2521551B2 (de)
AT (1) ATE88188T1 (de)
DE (1) DE69001309T2 (de)
DK (1) DK0383645T3 (de)
ES (1) ES2055875T3 (de)
FR (1) FR2644064B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760183A (en) * 1989-02-17 1998-06-02 Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
DE4111393A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Stabilisierte faktor viii-praeparationen
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
US4743680A (en) * 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
NL8701915A (nl) * 1987-08-14 1989-03-01 Waander Riethorst Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
EP0383645A1 (de) 1990-08-22
EP0383645B1 (de) 1993-04-14
DK0383645T3 (da) 1993-08-02
DE69001309T2 (de) 1993-08-05
ES2055875T3 (es) 1994-09-01
JP2521551B2 (ja) 1996-08-07
JPH02282400A (ja) 1990-11-19
FR2644064A1 (fr) 1990-09-14
FR2644064B1 (fr) 1994-05-27
DE69001309D1 (de) 1993-05-19

Similar Documents

Publication Publication Date Title
IE860305L (en) Method for purifying antihemophilic factor
DE60014047D1 (de) Verfahren zur reinigung von milchsäure auf industrieller basis
LV10053A (lv) Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
ATE87006T1 (de) Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
FI902017A0 (fi) Foerfarande foer rengoering av protein.
DE3886237D1 (de) Reinigung von LFA-3.
ATE131490T1 (de) Verfahren zur herstellung von gereinigten albuminlösungen
ATE166881T1 (de) Verfahren zur herstellung von faktor viii
ATE88188T1 (de) Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
EP0317627A4 (en) Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
DE69411492D1 (de) Verfahren zur Reinigung von mittleren Olefinen
ES2125938T3 (es) Procedimiento para la reactivacion de proteinas membranales purificadas.
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
DE3886118D1 (de) Methode zur Reinigung von Interferon.
DE69004244D1 (de) Verfahren zur Herstellung von hohen Anteilen des trans,trans-Isomeren enthaltenden 4,4'-Diisocyanatodicyclohexylmethan.
DE69026912D1 (de) Verfahren zur Herstellung von Nojirimycin-Verbindungen
DE68918436D1 (de) Adsorptives Trennungsverfahren zur Reinigung von 2,6-Dimethylnaphthalin.
ES8206549A1 (es) Procedimiento para la preparacion de nuevos analogos utiles de lincomicina y clindamicina.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee